I like it. I too use a price to sales ratio but I multiple it by...

First 6 Last

Share
Profile

Follow
Just_a_guy

3,322 Posts.

103

22/03/19

22:17

Post #: 37858847
Share

Originally posted by jogo: ↑

Pushpay is a typical high growth tech stock that has rapidly increasing revenue while at the same time it keeps making a loss because it is continually developing its product(s) and sales activity to increase its market and its revenue. So, using PE as a measure is not very effective and some other measure is needed to assess relative performance.
I am interested to learn from others how they value these high growth tech stocks like PPH. Some of them achieve increasing share prices along with growing revenues in the face of continuing losses.
One measure that I have been using is the ratio of SP to operating margin applied to revenue per share, which I call Price to Revenue at Margin. The operating margin gives some indication as to the profitability of the company while the ratio gives a valuation on a per share basis and allows companies of this nature to be compared on a vauation basis. For example, if a company has a margin of 83% with $1.82/share of revenue then the Revenue at Margin is $1.32/share. Take the SP and divide it by $1.32 to get the Price to Revenue at Margin. For waht it is worth, these figures apply to Xero which has not made a profit since its inception but whose revenue has grown strongly. Nevertheless, with today's SP of $49.35, its
Price to Revenue at Margin is 32.6.which I find high compared to other stocks. Compare that with PPH where I get a figure of 10.5. CAT comes in at 2.5, which is low and so PPH seems to be somewhere in the middle.

Expand

I like it. I too use a price to sales ratio but I multiple it by gross margin and expected growth rate.

PPH Price at posting: $3.14 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

There are more pages in this discussion • 17 more messages in this thread...

First 6 Last

Add PPH (ASX) to my watchlist

I like it. I too use a price to sales ratio but I multiple it by...

Top Stories

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Scientific conference spotlights PYC's work on blindness disease treatment

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Sales growth pushes Lovisa's fortunes (and shares) upwards

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse